Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2025 10:12 ET | Source: Research and Markets

Oncology Clinical Trials Market Research Report 2025 | Now Available

Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Oncology Clinical Trials Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The oncology clinical trials market size has...
October 22, 2025 10:44 ET | Source: Research and Markets

T-Cell Malignancies Pipeline Research Report 2025: Market Opportunities with Over 75 Companies and 80+ Drugs, Exploring Novel Treatments Like CAR-T Therapies and Targeted Therapies

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "T-Cell Malignancies - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report offers in-depth analysis of over 75...
October 21, 2025 05:34 ET | Source: Research and Markets

Tumor Infiltrating Lymphocytes Therapy Market Research Report 2025-2030: Market Driven by Active R&D from Iovance Biotherapeutics, Juncell Therapeutics, Biosyngen, and Instil Bio

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Global Tumor Infiltrating Lymphocytes Therapy Market Opportunity, Proprietary Technologies Platforms & Clinical Trials Insight 2030" report has...
October 13, 2025 07:59 ET | Source: Research and Markets

Conjugated Drugs (XDCs) in Oncology Market Intelligence Tool Launched – Covering 2,500+ Pipeline Drugs and 1,300+ Funding Rounds

Dublin, Oct. 13, 2025 (GLOBE NEWSWIRE) -- The "Unlocking Opportunity: Dominate the Market of Conjugated Drugs (XDCs) in Oncology with Confidence" directory has been added to ...
October 09, 2025 04:23 ET | Source: Research and Markets

Bispecific Antibodies Market - Global Forecast 2025-2032, Profiles of Key Players - F. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab

Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Bispecific Antibodies Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The global bispecific...
September 22, 2025 04:32 ET | Source: Research and Markets

Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024-2030: Advances in Next-Gen Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth

Dublin, Sept. 22, 2025 (GLOBE NEWSWIRE) -- The "Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024-2030" report has been added to ResearchAndMarkets.com's offering. The revenue...
September 02, 2025 06:06 ET | Source: Research and Markets

Immuno-oncology Clinical Trials Markets and Competition Report 2025-2030: Analysis by Therapy Type, Trial Phase, Indication, Sponsor Type, Trial Type, Patient Enrollment and Region

Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The "Immuno-oncology Clinical Trials Market by Therapy Type (Adoptive Cell Therapies, Cancer Vaccines, Checkpoint Inhibitors), Trial Phase (Phase I, Phase...
June 30, 2025 04:03 ET | Source: Research and Markets

Immuno-oncology: Diagnostics Pave the Path to Therapeutic Success

Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis" report has been added to ...
June 05, 2025 09:21 ET | Source: Research and Markets

Oncolytic Virus Immunotherapy Strategic Research Business Report 2025: Market to Reach $429.1 Million by 2030 - Breakthrough Designation Status and Fast Track Approvals Accelerate Regulatory Momentum

Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Immunotherapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
May 08, 2025 05:16 ET | Source: Research and Markets

Histone Deacetylase (HDAC) 6 Pipeline Landscape 2025: In-Depth Insights Into Over 20 Companies and 26 Drugs Within the HDAC 6 Inhibitors Pipeline

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Histone Deacetylase 6 - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. This report offers a detailed analysis...